[Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
D000638:Amiodarone / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002395:Catecholamines / Q000627:therapeutic use; D004573:Electrolytes / Q000378:metabolism; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D007473:Ion Channels / Q000187:drug effects*; D008012:Lidocaine / Q000627:therapeutic use; D011379:Prognosis; D011802:Quinidine / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D002395:Catecholamines; D004573:Electrolytes; D007473:Ion Channels; D008012:Lidocaine; D014700:Verapamil; D011802:Quinidine; D000638:Amiodarone
Effets cellulaires des médicaments anti-arythmiques. Leur valeur prédictive des effets thérapeutiques.